General Information
edit

Website	eyecyte.com
Category	BioTech
Phone	858-453-5800
Email
Employees
Description	Biotherapeutics

Offices
edit

La Jolla, USA

3366 North Torrey Pines Court
Suite 130
La Jolla, CA, 92037
USA

See nearby companies

People
edit

Mohammad A. El-Kalay

Founder, President and CEO

Noushin Dunkelman

Vice President, Process Development

Matthew R. Ritter

Manager, Research and Development

Funding
edit

Series A, 6/08
Pfizer Strategic Investments

$3M

Tags
edit

EyeCyte
edit

EyeCyte, Inc. is working with Pfizer’s Bioinnovation and iotherapeutics Center and The Scripps Research Institute to develop novel therapeutics to treat neovascular and degenerative retinal disease.

Milestones
edit

EyeCyte received $3M in Series A funding. (6/23/08)

Posted 6/8/09 at 1:49am
EyeCyte added Noushin Dunkelman as Vice President, Process Development .

Posted 6/8/09 at 1:49am
EyeCyte added Mohammad A. El-Kalay as Founder, President and CEO.

Posted 6/8/09 at 1:49am
EyeCyte added Matthew R. Ritter as Manager, Research and Development.

Posted 6/8/09 at 1:49am